BRCA1 and cancer: One of the first mechanisms of resistance identified is up-regulation of the multidrug resistance 1 (MDR1) transporter, initially reported in a genetically engineered BRCA1 mouse model [52](Figure 2A) and later in tissues from PARPi-treated cancers [53].